The global cell harvesting systems market size is expected to reach USD 22.98 billion by 2034, according to a new study by Polaris Market Research. The report “Cell Harvesting Systems Market Size, Share, Trends, Industry Analysis Report: By Technology (Blastomere Extraction and Altered Nuclear Transfer), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The cell harvesting systems market is experiencing significant growth, driven by increasing demand for regenerative medicine, immunotherapy, and biopharmaceutical production. Key drivers include the rising prevalence of chronic diseases, the growing need for personalized medicine, and advancements in cell-based therapies. Opportunities lie in the expansion of stem cell research and the development of innovative technologies, such as automated and closed-system solutions, which ensure higher efficiency and reduce contamination risks.
Major cell harvesting systems market trends include the integration of cell harvesting systems with regenerative medicine, particularly in oncology and stem cell therapies, and the shift towards automation in cell collection processes. As biopharmaceutical companies and research institutions invest in advanced technologies, the market is poised for continuous expansion, particularly in emerging regions like Asia Pacific, where healthcare infrastructure and biotechnology investments are on the rise.
Cell Harvesting Systems Market Report Highlights
Based on technology, the blastomere extraction segment held the largest market share in 2024 due to its widespread use in genetic testing and stem cell research, particularly in assisted reproductive technologies. Meanwhile, the altered nuclear transfer segment is projected to register the highest CAGR, driven by its potential in regenerative medicine and therapeutic cloning.
Based on application, the bone marrow segment dominated the market in 2024 due to its critical role in hematopoietic stem cell transplantation for blood-related disorders. Meanwhile, the umbilical cord segment is projected to experience the fastest growth, fueled by its rich stem cell content and expanding use in regenerative therapies.
Based on end user, the biotechnology and biopharmaceutical companies dominated the market with the largest share in 2024, driven by their extensive use of cell harvesting systems in drug development and production of cell-based therapies. The research centers segment is projected to register the fastest growth, supported by increasing investments in stem cell and regenerative medicine research.
North America dominated the market in 2024, driven by its advanced healthcare infrastructure, significant investments in biotechnology, and strong presence of key market players. The Asia Pacific cell harvesting systems market is anticipated to witness rapid growth during the projection period, driven by expanding healthcare systems, increasing research activities, and rising demand for cell-based therapies in the region.
Polaris Market Research has segmented the cell harvesting systems market research report on the basis of technology, application, end user, and region:
By Technology Outlook (Revenue – USD Billion, 2020–2034)
Blastomere Extraction
Altered Nuclear Transfer
By Application Outlook (Revenue – USD Billion, 2020–2034)
Bone Marrow
Umbilical Cord
Adipose Tissue
Peripheral Blood
By End User Outlook (Revenue – USD Billion, 2020–2034)
Research Centers
Biotechnology
Biopharmaceutical Companies
Diagnostic Labs
Others
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook